Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study
Fateme Azimi, Jahan B. Ghasemi, Homa Azizian, et al.
International Journal of Biological Macromolecules (2020) Vol. 166, pp. 1082-1095
Closed Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity
Honghui Liu, Puxin Huang, Xingchen Wang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107059-107059
Closed Access | Times Cited: 5
Exploring chalcone-sulfonyl piperazine hybrids as anti-diabetes candidates: design, synthesis, biological evaluation, and molecular docking study
Narges Hosseini Nasab, Hussain Raza, Young Seok Eom, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Synthesis, investigation of the crystal structure, DFT calculations, and in silico medicinal potential of hydrazono- and aminomethylene substituted pyrazolidine-3,5-diones as potential anticancer scaffolds
Youness El Bakri, Sabir Ali Siddique, Shaaban K. Mohamed, et al.
New Journal of Chemistry (2024) Vol. 48, Iss. 28, pp. 12591-12608
Closed Access | Times Cited: 1
Synthesis of Pyrazolo[3,4‐b]pyridine Derivatives and Their In‐Vitro and In‐Silico Antidiabetic Activities
Iqra Rafique, Tahir Maqbool, Muhammad Salman Javed
Journal of Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Pyrazole-based N-phenyl pyrazolines: Synthesis, docking, and pharmacological evaluation
Nargisbano A. Peerzade, Shravan Y. Jadhav, Raghunath B. Bhosale, et al.
Results in Chemistry (2024) Vol. 11, pp. 101793-101793
Open Access | Times Cited: 1
Exploring the therapeutic potential of benzothiazine-pyrazole hybrid molecules against alpha-glucosidase: Pharmacological and molecular modelling based approach
Saman Taj, Matloob Ahmad, Abdulrahman Alshammari, et al.
Saudi Journal of Biological Sciences (2021) Vol. 29, Iss. 3, pp. 1416-1421
Open Access | Times Cited: 13
Inhibition of α-glucosidase Enzyme By ‘click'-inspired Pharmacophore Framework 1,3,4-thiadiazole–1,2,3-triazole Hybrids
Manoj Dhameja, Hariom Kumar, Sirisha Kurella, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 4, pp. 345-363
Closed Access | Times Cited: 4
Coumarin linked thiazole derivatives as potential α-glucosidase inhibitors to treat diabetes mellitus
Rushikesh Ichale, Ashish M. Kanhed, Amisha Vora
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1239-1247
Closed Access | Times Cited: 4
Design, synthesis, and bio-evaluation of new isoindoline-1,3-dione derivatives as possible inhibitors of acetylcholinesterase
Motahareh Hassanzadeh, Farshid Hassanzadeh, Ghadamali Khodarahmi, et al.
Research in Pharmaceutical Sciences (2021) Vol. 16, Iss. 5, pp. 482-492
Open Access | Times Cited: 11
Synthesis, molecular dynamic, and in silico study of new ethyl 4-arylpyrimido[1,2-b]indazole-2-carboxylate: Potential inhibitors of α-glucosidase
Mojtaba Gashghaee, Homa Azizian, Mehdi Adib, et al.
Journal of Molecular Structure (2022) Vol. 1257, pp. 132507-132507
Closed Access | Times Cited: 7
Synthesis, design,in silico,in vitroandin vivo(streptozotocin-induced diabetes in mice) biological evaluation of novelsN-arylacetamide derivatives
Salma Mortada, Walid Guerrab, Mohcine Missioui, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 13, pp. 6711-6725
Open Access | Times Cited: 3
In Silico Identification of Promising New Pyrazole Derivative-Based Small Molecules for Modulating CRMP2, C-RAF, CYP17, VEGFR, C-KIT, and HDAC—Application towards Cancer Therapeutics
Fatima Ezzahra Bennani, Khalid Karrouchi, Latifa Doudach, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 11, pp. 5312-5351
Open Access | Times Cited: 6
Synthesis of 1,2,3‐triazole‐1,3,4‐thiadiazole hybrids as novel α‐glucosidase inhibitors by in situ azidation/click assembly
Hariom Kumar, Manoj Dhameja, Sirisha Kurella, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 8
Closed Access | Times Cited: 2
The antihyperglycemic potential of pyrazolobenzothiazine 1, 1-dioxide novel derivative in mice using integrated molecular pharmacological approach
Saman Taj, Usman Ali Ashfaq, Matloob Ahmad, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
In silico analysis of soybean phytocompounds against Plasmodium falciparum
Ayyagari Ramlal, Megha Khari, Pooja Jakhar, et al.
Journal of Herbal Medicine (2024) Vol. 46, pp. 100888-100888
Closed Access
Experimental and theoretical Investigation on vibrational, electronic and docking characteristics of 1-(3-nitro-phenyl)-5-phenyl-penta-2,4-dien-1-one (1NP5PP)
Shivaraj B. Radder, B. Siddlingeshwar, S.R. Manohara, et al.
Canadian Journal of Physics (2024) Vol. 102, Iss. 12, pp. 656-670
Closed Access
Synthesis and Molecular Docking of Curcumin‐Derived Pyrazole‐Thiazole Hybrids as Potent α‐Glucosidase Inhibitors
Jehan Y. Al‐Humaidi, Lamia A. Albedair, Deepika Maliwal, et al.
Chemistry & Biodiversity (2024)
Closed Access
Apigenin analogs as α-glucosidase inhibitors: Molecular docking, biochemical, enzyme kinetic, and an in vivo mouse model study
Honghui Liu, Yau‐Huei Wei, Yan Wang, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107956-107956
Closed Access
De novo unified robust antidiabetic pharmacophores based on biopotent hybrid material: DFT‐assisted design, optimized molecular structure, and understanding mechanism of antidiabetic bioassay
Anita Kumawat, Komal Soni, Sanjiv Saxena, et al.
Applied Organometallic Chemistry (2023) Vol. 37, Iss. 9
Closed Access | Times Cited: 1
Identification of novel pyrazole containing ɑ-glucosidase inhibitors: insight into pharmacophore, 3D-QSAR, virtual screening, and molecular dynamics study
Jannat ul Firdaus, Nadeem Siddiqui, Ozair Alam, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9398-9423
Open Access | Times Cited: 2
Coumarin linked thiazole derivatives as potential α-Glucosidase inhibitors to treat Diabetes Mellitus
Rushikesh Ichale, Ashish M. Kanhed, Amisha Vora
Research Square (Research Square) (2023)
Closed Access
The antihyperglycemic potential of pyraozolobenzothiazine 1,1-dioxide novel derivative in mice using integrated molecular pharmacological approach
Saman Taj, Usman Ali Ashfaq, Matloob Ahmad, et al.
Research Square (Research Square) (2023)
Open Access
Exploring chalcone-sulfonyl piperazine hybrids as anti-diabetes candidates: Design, synthesis, biological evaluation, and molecular docking study
Narges Hosseini Nasab, Hussain Raza, Young Seok Eom, et al.
Research Square (Research Square) (2023)
Open Access
Previous Page - Page 2

Scroll to top